Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival
mediaposted on 2021-05-18, 16:24 authored by Adis Rapid Journals on behalf of:, Agnieszka Maj-Hes, Tibor Szarvas, Sabina Sevcenco, Gero Kramer
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.